Impact of Semaglutide on Kidney, Cardiovascular, and Mortality Outcomes by Baseline BMI and Weight Loss in People with T2D and CKD: Data from the FLOW Trial
Authors:
Johannes F. E. Mann1,2; Katherine R. Tuttle3,4; Richard E. Pratley5; Kenneth W. Mahaffey6; Mustafa Arici7; Nicolas Belmar8; Karen Bonefeld8; Gil Chernin9; Ricardo Correa-Rotter10; Pieter Gillard11; Samy Hadjadj12; Thomas Idorn8; Linong Ji13; Soo Kun Lim14; Martin Linder8; Roland Schmieder15; Minara Shamkhalova16; Apiradee Sriwijitkamol17; Vlado Perkovic18; Peter Rossing19